Related Articles
Co-expression of P1A35-43/β2m fusion protein and co-stimulatory molecule CD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumor model
MHC class I down-regulation: tumour escape from immune surveillance? (Review)
P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway
Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2
A study on anti-tumor immunity induced by gene-modified melanoma B16 cells